Covered recipient · General Payments record
AYMAN ABDULAZIZ M MUKHTAR
Allopathic & Osteopathic Physicians Internal Medicine Hematology
General Payments · PY2025
$761.29
- Reported across 8 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $611.31 | 6 |
| Education | $149.98 | 2 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $217.24 | 2 |
| Astellas Pharma US Inc | $149.98 | 2 |
| Janssen Biotech, Inc. | $134.00 | 1 |
| Stemline Therapeutics Inc. | $122.56 | 1 |
| Geron Corporation | $109.23 | 1 |
| Adaptive Biotechnologies Corporation | $28.28 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2025 | $761.29 | 8 |
Payment records · PY2025 (8)
Ordering applied by this site (paying entity, then date) · record values are shown as CMS published them
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Adaptive Biotechnologies Corporation | $28.28 | 05/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1254936056 | CMS |
| Astellas Pharma US Inc | $49.99 | 07/30/2025 | Education | Undisputed | 06/30/2026 | 1238616508 | CMS |
| Astellas Pharma US Inc | $99.99 | 07/30/2025 | Education | Undisputed | 06/30/2026 | 1238616510 | CMS |
| E.R. Squibb & Sons, L.L.C. | $97.06 | 05/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1184482441 | CMS |
| E.R. Squibb & Sons, L.L.C. | $120.18 | 11/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1184482457 | CMS |
| Geron Corporation | $109.23 | 05/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238891738 | CMS |
| Janssen Biotech, Inc. | $134.00 | 11/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1175192878 | CMS |
| Stemline Therapeutics Inc. | $122.56 | 04/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1244090615 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2025
- Source files
- Dataset page · Bulk file · PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.